BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 18449905)

  • 1. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
    Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
    J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells.
    Singhatanadgit W; Salih V; Olsen I
    Cell Biol Int; 2008 Nov; 32(11):1362-70. PubMed ID: 18773965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function.
    Abdelmagid SM; Barbe MF; Arango-Hisijara I; Owen TA; Popoff SN; Safadi FF
    J Cell Physiol; 2007 Jan; 210(1):26-37. PubMed ID: 17034042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
    Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
    Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2.
    Gutierrez J; Osses N; Brandan E
    J Cell Physiol; 2006 Jan; 206(1):58-67. PubMed ID: 15920756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
    Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
    Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo.
    Zhou H; Qian J; Wang J; Yao W; Liu C; Chen J; Cao X
    Biomaterials; 2009 Mar; 30(9):1715-24. PubMed ID: 19131102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porcine sinus mucosa holds cells that respond to bone morphogenetic protein (BMP)-6 and BMP-7 with increased osteogenic differentiation in vitro.
    Gruber R; Kandler B; Fuerst G; Fischer MB; Watzek G
    Clin Oral Implants Res; 2004 Oct; 15(5):575-80. PubMed ID: 15355400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP stimulation of alkaline phosphatase activity in pluripotent mouse C2C12 cells is inhibited by dermatopontin, one of the most abundant low molecular weight proteins in demineralized bone matrix.
    Behnam K; Murray SS; Brochmann EJ
    Connect Tissue Res; 2006; 47(5):271-7. PubMed ID: 17118749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cartilage-derived morphogenetic proteins enhance the osteogenic protein-1-induced osteoblastic cell differentiation of C2C12 cells.
    Yeh LC; Tsai AD; Zavala MC; Lee JC
    J Cell Physiol; 2004 Dec; 201(3):401-8. PubMed ID: 15389555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
    Kuo PL; Hsu YL; Chang CH; Chang JK
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of a mesenchymal cell line that differentiates into osteoblasts in response to BMP-2 from calvariae of GFP transgenic mice.
    Kadowaki A; Tsukazaki T; Hirata K; Shibata Y; Okubo Y; Bessho K; Komori T; Yoshida N; Yamaguchi A
    Bone; 2004 Jun; 34(6):993-1003. PubMed ID: 15193545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone formation on apatite-coated titanium incorporated with bone morphogenetic protein and heparin.
    Kodama T; Goto T; Miyazaki T; Takahashi T
    Int J Oral Maxillofac Implants; 2008; 23(6):1013-9. PubMed ID: 19216269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
    Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F
    J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation.
    de Gorter DJ; van Dinther M; Korchynskyi O; ten Dijke P
    J Bone Miner Res; 2011 Jun; 26(6):1178-87. PubMed ID: 21611961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
    Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
    Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation.
    Nakagawa K; Imai Y; Ohta Y; Takaoka K
    Bone; 2007 Oct; 41(4):543-8. PubMed ID: 17681894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxysterol-induced osteoblastic differentiation of pluripotent mesenchymal cells is mediated through a PKC- and PKA-dependent pathway.
    Richardson JA; Amantea CM; Kianmahd B; Tetradis S; Lieberman JR; Hahn TJ; Parhami F
    J Cell Biochem; 2007 Apr; 100(5):1131-45. PubMed ID: 17031848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.